Search

Search Results

• Efficacy, Safety, and Tolerance of Gemtuzumab Ozogamicin Combined with FLAG/FLAG-Ida or Azacitidine in Relapsed/Refractory Acute Myeloblastic Leukemia

  Irina Garmaevna Budaeva, D.V. Zaitsev, A.A. Shatilova, E.N. Tochenaya, A.V. Petrov, R.I. Vabishchevich, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, S.V. Efremova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  299-307

  01.07.2021

• Comparative Analysis of Myelofibrosis Treatment Outcomes with the Use of Ruxolitinib Versus Ruxolitinib with Subsequent Allogeneic Hematopoietic Stem Cell Transplantation

  Mariya Vladimirovna Barabanshchikova, E.V. Morozova, Yu.Yu. Vlasova, T.L. Gindina, A.V. Evdokimov, I.M. Barkhatov, V.V. Baikov, I.O. Ivanova, T.A. Rudakova, E.A. Bakin, I.S. Moiseev, A.D. Kulagin

  22-30

  01.01.2021

• Effect of Patients’ Endocrine Status on Effectiveness of Treatment with Rituximab: State of the Art

  Yuliya Valer’evna Komoza, V.A. Komoza, S.V. Chernavskii, O.A. Rukavitsyn

  187-190

  01.04.2017

• Quality of life in adolescent and young adult Hodgkin’s lymphoma survivors

  Ye.G. Arshanskaya, S.V. Semochkin, A.G. Rumyantsev

  184-191

  01.04.2014